Marc Hinterthaner

1.0k total citations
38 papers, 680 citations indexed

About

Marc Hinterthaner is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Marc Hinterthaner has authored 38 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Marc Hinterthaner's work include Lung Cancer Diagnosis and Treatment (9 papers), Myasthenia Gravis and Thymoma (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Marc Hinterthaner is often cited by papers focused on Lung Cancer Diagnosis and Treatment (9 papers), Myasthenia Gravis and Thymoma (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Marc Hinterthaner collaborates with scholars based in Germany, United States and Japan. Marc Hinterthaner's co-authors include Klaus Fink, Eberhard Schlicker, M. G�thert, Alexander Emmert, Georgios Stamatis, Hanibal Bohnenberger, Ludger Hillejan, Thomas Krbek, Judith Buentzel and Judith Heinz and has published in prestigious journals such as Journal of Thoracic and Cardiovascular Surgery, The Annals of Thoracic Surgery and Medicine.

In The Last Decade

Marc Hinterthaner

35 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Hinterthaner Germany 13 224 188 187 112 105 38 680
Vittorio D’Aguanno Italy 10 81 0.4× 98 0.5× 73 0.4× 49 0.4× 50 0.5× 18 565
Yoon Hee Chang South Korea 7 84 0.4× 216 1.1× 125 0.7× 21 0.2× 75 0.7× 20 908
M Magarò Italy 16 73 0.3× 73 0.4× 98 0.5× 39 0.3× 64 0.6× 45 678
Mitsuhiro Narita Japan 11 128 0.6× 175 0.9× 39 0.2× 11 0.1× 74 0.7× 46 589
Lixia Yang China 13 93 0.4× 92 0.5× 95 0.5× 27 0.2× 17 0.2× 49 697
Flavia R. Greiffo Brazil 12 319 1.4× 255 1.4× 142 0.8× 10 0.1× 127 1.2× 23 753
K Rajakulasingam United Kingdom 16 299 1.3× 56 0.3× 197 1.1× 43 0.4× 714 6.8× 41 991
Yoriko Murata Japan 13 88 0.4× 64 0.3× 32 0.2× 32 0.3× 33 0.3× 44 646
Wonjae Cha South Korea 16 143 0.6× 73 0.4× 24 0.1× 26 0.2× 142 1.4× 69 631
Fumiko Date Japan 13 136 0.6× 140 0.7× 61 0.3× 8 0.1× 59 0.6× 22 632

Countries citing papers authored by Marc Hinterthaner

Since Specialization
Citations

This map shows the geographic impact of Marc Hinterthaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Hinterthaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Hinterthaner more than expected).

Fields of papers citing papers by Marc Hinterthaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Hinterthaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Hinterthaner. The network helps show where Marc Hinterthaner may publish in the future.

Co-authorship network of co-authors of Marc Hinterthaner

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Hinterthaner. A scholar is included among the top collaborators of Marc Hinterthaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Hinterthaner. Marc Hinterthaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tirilomis, Petros, Marc Hinterthaner, Bernhard C. Danner, et al.. (2024). Expression and prongostic impact of galectin-7 in human lung cancer. Medicine. 103(40). e39911–e39911.
2.
Li, Yuchan, Marc Hinterthaner, Bernhard C. Danner, et al.. (2023). Expression and prognostic impact of DNA-PK in human lung cancer. Medicine. 102(9). e33143–e33143. 1 indexed citations
4.
Overbeck, Tobias R., Katja Schmitz, Achim Rittmeyer, et al.. (2023). NTRK Gene Fusions in Non-Small-Cell Lung Cancer: Real-World Screening Data of 1068 Unselected Patients. Cancers. 15(11). 2966–2966. 12 indexed citations
5.
Küffer, Stefan, Satoru Okada, Stefan Welter, et al.. (2022). Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas. Cancers. 14(19). 4762–4762. 2 indexed citations
6.
Li, Yuchan, Marc Hinterthaner, Bernhard C. Danner, et al.. (2022). Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma. Metabolites. 12(7). 652–652. 7 indexed citations
7.
Shafie, Rami A. El, Andrea Hille, Markus Schirmer, et al.. (2022). Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome. Strahlentherapie und Onkologie. 198(12). 1072–1081. 5 indexed citations
8.
Küffer, Stefan, et al.. (2021). One carbon metabolism in human lung cancer. Translational Lung Cancer Research. 10(6). 2523–2538. 19 indexed citations
9.
Overbeck, Tobias R., Katja Schmitz, Achim Rittmeyer, et al.. (2020). Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis. Translational Lung Cancer Research. 9(3). 603–616. 21 indexed citations
10.
Buentzel, Judith, Judith Heinz, Annalen Bleckmann, et al.. (2019). Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-analysis. Anticancer Research. 39(9). 4603–4612. 71 indexed citations
11.
Bohnenberger, Hanibal, Julia Beck, Kirsten Bornemann-Kolatzki, et al.. (2019). Molecular Classification of Neuroendocrine Tumors of the Thymus. Journal of Thoracic Oncology. 14(8). 1472–1483. 42 indexed citations
12.
Uhlig, Annemarie, et al.. (2019). Surgical approaches for treatment of ureteropelvic junction obstruction – a systematic review and network meta-analysis. BMC Urology. 19(1). 112–112. 17 indexed citations
13.
Hinterthaner, Marc, et al.. (2016). Acute respiratory distress syndrome after aspiration of lamp oil in a fire-eater: a case report. Journal of Medical Case Reports. 10(1). 193–193. 3 indexed citations
14.
Russo, Sebastian G., et al.. (2016). Trachealer Bronchusabgang und kontralaterale Pneumonektomie. Der Anaesthesist. 65(8). 590–594. 2 indexed citations
15.
Emmert, Alexander, Karsten Schmidt, Marc Hinterthaner, et al.. (2014). Aneurysm of the Pulmonary Vein: An Unusual Cause of Stroke. The Annals of Thoracic Surgery. 98(5). 1841–1843. 7 indexed citations
16.
Haarmann, Helge, Tobias Raupach, Julia Kitz, Marc Hinterthaner, & Stefan Andreas. (2012). EBUS-TBNA in a Case of Mediastinal Lymphangioma. Journal of Bronchology & Interventional Pulmonology. 19(2). 153–155.
17.
Raupach, Tobias, Michael Quintel, & Marc Hinterthaner. (2010). Präoperative Tabakentwöhnung bei Patienten mit Bronchialkarzinom. Pneumologie. 64(11). 694–700. 8 indexed citations
18.
Welter, Stefan, Marc Hinterthaner, & Georgios Stamatis. (2006). Heart failure following left-sided pneumonectomy in a patient with known pectus excavatum — successful treatment using the Ravitch procedure. European Journal of Cardio-Thoracic Surgery. 29(4). 630–631. 1 indexed citations
19.
Stamatis, Georgios, et al.. (2005). Repeat Mediastinoscopy as a Restaging Procedure. Pneumologie. 59(12). 862–866. 50 indexed citations
20.
Kukuk, G, et al.. (2004). Gestieltes Leberhämangiom. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(6). 902–903. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026